Table 4.
Oral glucose tolerance test, HOMA and glycosylated hemoglobin in groups at baseline and 16 weeks
| Experimental | Control | |||
|---|---|---|---|---|
| Basal (0 weeks) | Final (16 weeks) | Basal (0 weeks) | Final (16 weeks) | |
| Postprandial glycemia 120 min (mg/dL) | 85.0 ± 28.9 | 89.1 ± 34.2 | 82.7 ± 19.1 | 83.7 ± 34.8 |
| Fasting insulin (mg/dL) | 12.5 ± 8.3 | 11.8 ± 8.9 | 10.3 ± 4.6 | 8.9 ± 4.4 |
| Postprandial insulin 120 min (mg/dL) | 67.1 ± 68.3 | 60.3 ± 59.6* | 57.8 ± 57.0 | 77.0 ± 97.2* |
| HOMA | 2.90 ± 2.05 | 2.65 ± 2.17 | 2.30 ± 1.10 | 1.93 ± 1.02 |
| Glycosylated hemoglobin (%) | 5.2 ± 0.3a | 5.5 ± 0.3b | 5.1 ± 0.3a | 5.3 ± 0.3b |
Values are mean ± SD. Student t-test for paired samples was used to analyze differences of means within groups. Student t-test for independent samples was used to analyze differences of means between groups. Means within a group with different superscript letters are significantly different; P < 0.05 paired t test
* Indicate statistically significant differences in the changes produced by the intervention between the groups (P < 0.05, paired t test)